Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter

FierceBiotechEntrada's stock craters as DMD data underperform expectations, handing advantage to Novartis

FierceBiotechRoche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics

Promega BlogWhat Counts as Evidence

FierceBiotechFrom drug development to M&A, Big Pharmas showcase AI’s ‘measurable impact’

Lonza NewsBMS Licenses SYNtecan Linker-Payload Platform from Lonza - Contract Pharma

IlluminaAi In Genomics Market Is Going to Boom | Illumina, IBM, Google - openPR.com

Endpoints NewsAtara, Pierre Fabre's cell therapy to get another shot at FDA approval

FierceBiotechInsulet boosts guidance in Q1 update as it grapples with recall saga

PharmaVoiceLilly, Gilead lead pharma’s M&A boom

LabiotechThe rise of trispecific antibodies: Biopharma’s next big bet after bispecifics

Endpoints NewsPennsylvania sues AI chatbot company for posing as a licensed doctor

Novo NordiskNovo Nordisk faces competition from Canada compounders - medwatch.com